ArticleCureus2026
Legionnaires' Disease Presenting With Erythema Multiforme in an Immunocompetent Patient.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Legionnaires' disease is a severe form of pneumonia most commonly caused by Legionella pneumophila serogroup 1. While primarily affecting the lungs, extrapulmonary manifestations such as hyponatremia, renal dysfunction, and hepatic involvement are well described. In contrast, cutaneous manifestations are rare and remain poorly characterized. We report the case of a 62-year-old immunocompetent man with a history of chronic alcohol use and active smoking who presented with fever, dyspnea, and productive cough. On admission, he was febrile (38.5°C), tachycardic, and had crackles over the right lower lung field. Laboratory evaluation revealed hyponatremia (132 mmol/L) and markedly elevated inflammatory markers (CRP 480 mg/L, procalcitonin 41 ng/mL). Chest imaging demonstrated right lower lobe pneumonia. Initial empiric therapy with amoxicillin-clavulanate was started. Within 48 hours, the patient developed acute respiratory failure requiring intubation and ICU admission. Urinary antigen testing confirmed Legionella pneumophila infection, and antibiotic therapy was switched to levofloxacin and spiramycin. The course was complicated by severe ARDS (PaO₂/FiO₂ ratio 100) requiring prone positioning, and septic shock requiring vasopressors. On day 9 of hospitalization (seven days after targeted therapy initiation), the patient developed a diffuse, non-pruritic erythematous maculopapular rash with targetoid lesions, involving the trunk and limbs, with palmar involvement and petechiae at the ankles, without mucosal involvement. A drug eruption was initially suspected; however, skin biopsy showed mild interkeratinocytic edema with superficial lymphocytic infiltrate and rare keratinocyte necrosis, without eosinophilia or features of toxidermia. Direct immunofluorescence and PCR testing for herpes simplex virus and Mycoplasma pneumoniae were negative. These findings supported a diagnosis of erythema multiforme (EM) secondary to Legionella infection. The rash resolved spontaneously without specific treatment. The patient improved clinically, was extubated on day 12, weaned off vasopressors by day 10, and discharged on day 20 after completing antibiotic therapy. This case illustrates a rare presentation of Legionnaires' disease complicated by EM. Recognition of this association is important, as cutaneous findings may mimic drug reactions and lead to inappropriate modification of effective antimicrobial therapy. This report contributes to the limited literature describing dermatologic manifestations of Legionella infection and underscores the need for clinical awareness of this uncommon presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.